ULUR — Altrazeal Life Sciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Altrazeal Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.005 | 0.55 | 0.18 | 0.037 | 3.71 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.963 | 0.802 | 0.092 | 0.062 | 0.256 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.49 | 1.82 | 0.927 | 0.793 | 4.64 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.639 | 0.432 | 0.257 | 0.127 | 0.054 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 5.9 | 5.46 | 7.43 | 4.34 | 8.54 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.27 | 1.87 | 2.54 | 2.41 | 1.51 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.17 | 2.71 | 3.23 | 2.77 | 2.44 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.73 | 2.75 | 4.2 | 1.57 | 6.11 |
Total Liabilities & Shareholders' Equity | 5.9 | 5.46 | 7.43 | 4.34 | 8.54 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |